What does it mean that this is an amendment (10-K/A)?

A 10-K/A filing indicates that Merck & Co., Inc. is amending its previously filed annual report (10-K). This typically occurs when the company identifies errors, omissions, or needs to provide updated information after the original filing. Investors should review the content of the amendment carefully to understand what has been changed and why.

What period does this filing cover?

This amended filing covers the fiscal year for Merck & Co., Inc. that ended on December 30, 1995.

Why might there be a delay between the period end and the filing date?

The filing date of June 25, 1996, for a period ending December 30, 1995, suggests a significant gap. This could be due to the complexity of preparing the financial statements and disclosures, the need for extensive audits, or, in the case of an amendment, the process of identifying and correcting information in the original filing.

Where can I find the actual financial details and business operations information?

The provided text is only the metadata and directory listing for the filing. The full financial statements, management's discussion and analysis, and other detailed disclosures would be contained within the actual report document, typically a .txt file accessible through the SEC's EDGAR system.

MRK 10-K Filed Jun 26, 1996

Summary

This filing represents an amendment to Merck & Co., Inc.'s 1995 Annual Report (10-K). As an amendment, it suggests that the original filing may have contained errors or omissions that have since been corrected. Investors should note that this filing provides updated information for the fiscal year ending December 30, 1995. While the provided text is limited to the filing metadata and directory structure, it indicates that the full financial and operational details would be contained within the associated .txt file, which is not included in this snippet.

Key Highlights

1Amendment to the 1995 10-K filing for Merck & Co., Inc. (MRK).
2The filing pertains to the fiscal year ending December 30, 1995.
3Filed on June 25, 1996, indicating a potential delay or update to the original filing.
4The amendment suggests a need for correction or supplementation of previously reported information.
5The full financial and narrative details are expected to be within the associated .txt file, not provided here.

Merck & Co., Inc. Annual Report (Amendment), Year Ended Dec 31, 1995

Summary

Key Highlights

Frequently Asked Questions